Search the Newsroom
Filter By
Showing 2581 - 2590 of 3020 results
CHOP to Lead New Pediatric Data Resource Center for Research in Childhood Cancer, Birth Defects
Funds from Gabriella Miller Kids First Pediatric Research Program will establish a 'first-in-kind' data discovery and sharing platform to support collaborative pediatric research.
“Breastfeeding” Carries Different Connotations for Mothers in N/IICU
Researchers at Children’s Hospital of Philadelphia (CHOP) are learning what breastfeeding means to mothers of seriously ill babies and how setting attainable breastfeeding goals can help their babies in the N/IICU.
Summer Fun Gets a Little Bit Easier for Children with Special Needs
Simple tips for families of children with autism to make the most out of summer fun spots.
CHOP Leads Child Safety Project through Toyota Collaborative Safety Research Center
The research will focus on how passengers move and brace themselves during crash avoidance maneuvers.
Simultaneously Weaker and Stronger? New Brain Research Begins to Makes Sense of a Longstanding Paradox
New research suggests that people with autism may simultaneously have conflicting differences in strength of brain network connections
3 CHOP Scientists Win Bayer Grants for Hemophilia Research
Three CHOP researchers recently won grants for their work on hemophilia from the Bayer Hemophilia Awards Program.
Dr. Katherine Dahlsgaard Named 2017 Psychology in Media Award Winner
Dr. Dahlsgaard Recognized by the Pennsylvania Psychological Association for her efforts to bring evidence-based psychology to the public through the media.
CHOP Experts Travel to Foshan, China
The multidisciplinary team from CHOP partnered with colleagues abroad to share knowledge and clinical expertise.
Doctors Investigate Sudden Paralysis in Kids
6ABC interviews a CHOP patient family and neurologist Sarah Hopkins, MD, about acute flaccid myelitis, a condition causing sudden paralysis in some kids.
FDA Committee Recommends Approving First Cell Therapy to Successfully Treat Cancer
The experimental, personalized cell therapy that amps up the patient's own immune system has passed a critical milestone in the path to full FDA approval.